Biologics Market: Is 2026 the Year "Sustainable Bioprocessing" Becomes a Regulatory Mandate
The 2026 Biologics Market is going "Green." As global environmental regulations tighten, 2026 has become the year of "Sustainable Bioproduction," where the "Carbon Footprint" of a drug is as scrutinized as its clinical efficacy. The 2026 market is seeing a massive shift toward "Single-Use Bioreactors," which now hold a 61.8% share of the manufacturing segment. These 2026 systems eliminate the...
0 ความคิดเห็น 0 แชร์ 674 ยอดวิว 0 รีวิว